Standardization of antifungal susceptibility testing

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 4, 1996, Pages 561-578

  Cormican, M G ^a   Pfaller, M A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

CLINICAL RESEARCH; DRUG SENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; REPRODUCIBILITY; REVIEW; STANDARDIZATION; THRUSH;

EID: 0029844621     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.4.561     Document Type: Review

References (74)

1. Anaissie, E. J., Karyotakis, N. C., Hachem, R., Dignani, M. C., Rex, J. H. & Paetznick, V. (1994). Correlation between in vitro and in vivo activity of antifungal agents against Candida species. Journal of Infectious Disease 170, 384-9.
2. Anaissie, E., Paetznick, V. & Bodey, G. P. (1991). Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrobial Agents and Chemotherapy 35, 1641-6.
3. Baily, G. G., Perry, F. M., Denning, D. W. & Mandal, B. K. (1994). Fluconazole-resistant candidiasis in a HIV cohort. AIDS 8, 787-92.
4. Barchiesi, F., Colombo, A. L., McGough, D. A. & Rinaldi, M. G. (1994). Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards, proposed standard. Journal of Clinical Microbiology 32, 2494-500.
5. Barchiesi, F., Hollis, R. J., McGough, D. A., Scalise, G., Rinaldi, M. G. & Pfaller, M. A. (1995). DNA sybtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clinical Infectious Disease 20, 634-40.
6. Barry, A. L., Pfaller, M. A. & Fuchs, P. C. (1993). Dirithromycin disc susceptibility tests: interpretive criteria and quality control parameters. Journal of Antimicrobial Chemotherapy 31, Suppl. C, 27-37.
7. Bryce, E., Roberts, F., Sekhon, A. & Coldman, A. (1992). Yeast in blood cultures. Evaluation of factors influencing outcome. Diagnostic Microbiology and Infectious Disease 15, 233-7.
8. Cameron, M. L., Schell, W. A., Bruch, S., Bartlett, J. A., Waskin, H. A. & Perfect, J. R. (1993). Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type I. Antimicrobiol Agents and Chemotherapy 37, 2449-53.
9. Colombo, A. L., Barchiesi, F., McGough, D. A. & Rinaldi, M. G. (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. Journal of Clinical Microbiology 33, 535-40.
10. Espinel-Ingroff, A. (1994). E test for antifungal susceptibility testing of yeasts. Diagnostic Microbiology and Infectious Disease 19, 217-20.
11. Espinel-lngroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D. et al. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 39, 314-9.
12. Espinel-lngroff, A. & Kerkering, T. M. (1991). Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. Journal of Clinical Microbiology 29, 393-4.
13. Espinel-lngroff, A., Kerkering, T. M., Goldston, P. R. & Shadomy, S. (1991). Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 29, 1089-1094.
14. Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N. et al. (1992). Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 30, 3138-45.
15. Espinel-Ingroff, A. & Pfaller, M. A. (1995). Antifungal agents and susceptibility testing. In Manual of Clinical Microbiology, 6th edn (Murray, P., Baron, E., Pfaller, M., Tenover, F. & Yolken, R., Eds), pp. 1405-14. American Society for Microbiology, Washington, DC.
16. Espinel-Ingroff, A., Pfaller, M., Erwin, M. E. & Jones, R. N. (1996). An interlaboratory evaluation of the Etest method for antifungal susceptibility testing of pathogenic yeasts for five antifungal agents using casitone agar and solidified RPMI 1640 medium with 2% glucose. Journal of Clinical Microbiology, 38, 848-52.
17. Espinel-Ingroff, A. & Steele-Moore, L. (1994). Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640. Diagnostic Microbiology and Infectious Disease 20, 87-91.
18. Espinel-Ingroff, A., Steele-Moore, L. & Galgiani, J. N. (1994). Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories. Diagnostic Microbiology and Infectious Disease 20, 81-6.
19. Fournier, C., Caspar, A., Bordlot, F. & Villard, J. (1995). Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures. Journal of Antimicrobial Chemotherapy 35, 373-80.
20. Galgiani, J. N. (1993). Susceptibility testing of fungi: current status of the standardization process. Antimicrobiol Agents and Chemotherapy 37, 2517-21.
21. Galgiani, J. N., Reiser, J., Brass, C., Espinel-Ingroff, A., Gordon, M. A. & Kerkering, T. M. (1987). Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrobial Agents and Chemotherapy 31, 1343-47.
22. Gehrt, A., Peter, J., Pizzo, P. A. & Walsh, T. J. (1995). Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. Journal of Clinical Microbiology 33, 1302-7.
23. Graybill, J. R., Najvar, L. K., Holmberg, J. D., Correa, A. & Luther, M. F. (1995). Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response. Antimicrobial Agents and Chemotherapy 39, 2192-200.
24. Greenwood, D. (1981). In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. Journal of Infectious Disease 144, 380-5.
25. Hacek, D. M., Noskin, G. A., Trakas, K. & Peterson, L. R. (1995). Initial use of a broth microdilution method suitable for in vitro testing of fungal isolates in a clinical microbiology laboratory. Journal of Clinical Microbiology 33, 1884-9.
26. Hitchcock, C. A., Pye, G. W., Troke, P. F., Johnson, E. M. & Warnock, D. W. (1993). Fluconazole resistance in Candida glabrata. Antimicrobial Agents and Chemotherapy 37, 1962-5.
27. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. Journal of Antimicrobiol Chemotherapy 35, 103-14.
28. Law, D., Moore, C. B., Wardle, H. M., Gonguli, L. A., Keaney, M. G. L. & Denning, D. W. (1994). High prevalence of antifungal resistance in Candida spp. from patients with AIDS. Journal of Antimicrobiol Chemotherapy 34, 659-68.
29. McCabe, W. R. & Treadwell, T. L. (1985). In vitro susceptibility tests: correlations between sensitivity testing and clinical outcome in infected patients. In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V., Ed.), pp. 925-37. Williams and Wilkins, Baltimore, MD.
30. Messer, S. A. & Pfaller, M. A. (1996). Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing. Diagnostic Microbiology and Infectious Diseases, in press.
31. National Committee for Clinical Laboratory Standards (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts - Proposed Standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, PA.
32. National Committee for Clinical Laboratory Standards (1994). Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters. Approved Guidelines M23-A. National Committee for Clinical Laboratory Standards, Villanova, PA.
33. Odds, F. C., Vranckx, L. & Woestenborghs, F. (1995). Antifungal susceptibility testing of yeasts: evaluation of technical variables for research automation. Antimicrobial Agents and Chemotherapy 39, 2051-60.
34. Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. & Wenzel, R. P. (1991). Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9 year study. Journal of Clinical Oncology 9, 77-84.
35. Pfaller, M. A. (1996). Nosocomial candidiasis, emerging species, reservoirs, and modes of transmission. Clinical Infectious Diseases, 22, Suppl. 2, S89-94.
36. Pfaller, M. A. & Barry, A. L. (1994). Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 32, 1992-6.
37. Pfaller, M. A. & Barry, A. L. (1995). In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopalhologia 130, 3-9.
38. Pfaller, M. A., Bale, M., Buschelman, B., Lancaster, M., Espinel-Ingroff, A., Rex, J. H. et al. (1995a). Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flueytosine. Journal of Clinical Microbiology 33, 1104-7.
39. Pfaller, M. A., Buschelman, B., Bale, M. J., Lancaster, M., Espinel-Ingroff, A., Rex, J. H. et al. (1994a). Multi-center comparison of a colorimetric microdilution broth method with the reference microdilution method for in vitro susceptibility testing of yeast isolates. Diagnostic Microbiology and Infectious Disease 19, 9-13.
40. Pfaller, M. A., Dupont, B., Kobayashi, G. S., Muller, J., Rinaldi, M. G, Espinel-Ingroff, A. et al. (1992a). Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrobial Agents and Chemotherapy 36, 1805-9.
41. Pfaller, M. A., Grant, C., Morthland, V. & Rhine-Chalberg, J. (19946). Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. Journal of Clinical Microbiology 32, 506-9.
42. Pfaller, M. A., Jones, R. N., Washington, J. A., Koontz, F. P., Gerlach, E. H. & Erwin, M. E. (1992b). Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using haemophilus test medium. Diagnostic Microbiology and Infectious Disease 15, 145-50.
43. Pfaller, M. A., Messer, S. A. & Coffmann, S. (1995A). Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole, D0870. Journal of Clinical Microbiology 33, 1094-7.
44. Pfaller, M. A., Messer, S. A. & Hollis, R. J. (1994c). Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagnostic Microbiology and Infectious Disease 20, 127-33.
45. Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Farinaccio, G., Fothergill, A. W. et al. (1994d). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Journal of Clinical Microbiology 32, 59-64.
46. Pfaller, M. A. & Rinaldi, M. G. (1993). Antifungal susceptibility testing. Current state of technology, limitations, and standardization. Infectious Disease Clinics of North America 7, 435-44.
47. Pfaller, M. A., Rinaldi, M. G., Galgiani, J. N., Bartlett, M. S., Body, B. A., Espinel-Ingroff, A et al. (1990). Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrobial Agents Chemotherapy 34, 1648-54.
48. Pfaller, M. A., Vu, Q., Lancaster, M., Espinel-Ingroff, A., Fothergill, A., Grant, C. et al. (1994e). Multi-site reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 32, 1625-8.
49. Pfaller, M. & Wenzel, R. (1992). Impact of the changing epidemiology of fungal infections in the 1990s. European Journal of Clinical Microbiology and Infectious Disease 11, 287-91.
50. Polanco, A. M., Rodriguez-Tudela, J. L., Baquero, F., Sanchez-Sousa, A. & Martinez-Suarez, J. V. (1995). Improved method of determining the susceptibility of Candida albicans to fluconazole. Journal of Antimicrobial Chemotherapy 35, 155-9.
51. Powderly, W. G., Kobayashi, G. S., Herzig, G. P. & Medoff, G. (1988). Amphotericin B resistant yeast infection in severely immunocompromised patients. American Journal of Medicine 84, 826-32.
52. Redding, S., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A., Rhine-Chalberg, J. et al. (1994). Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation of in vitro susceptibility testing and DNA subtype analysis. Clinical Infectious Disease 18, 240-2.
53. Rex, J. H., Cooper, C. R., Merz, W. G., Galigiani, J. N. & Anaissie, E. J. (1995a). Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrobial Agents and Chemotherapy 39, 906-9.
54. Rex, J. H., Pfaller, M. A., Barry, A. L., Nelson, P. W. & Webb, C. D. (1995b). Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrobial Agents and Chemotherapy 39, 40-4.
55. Rex, J. H., Pfaller, M. A., Lancaster, M., Odds, F. C., Bolmström, A. & Rinaldi, M. G. (1996). Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of ketoconazole and itraconazole. Journal of Clinical Microbiology 34, 816-7.
56. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiological Reviews 6, 367-81.
57. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995c). Resistance of Candida species to fluconazole. Antimicrobial Agents and Chemotherapy 39, 1-8.
58. Rodriguez-Tudela, J. L. & Martinez-Suarez, J. V. (1995). Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. Journal of Antimicrobial Chemotherapy 35, 739-49.
59. Rodriguez-Tudela, J. L., Martinez-Suarez, J. V., Dronda, F., Laguna, F., Chaves, F. & Valencia, E. (1995). Correlation of in vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy 35, 793-804.
60. Ruhnke, M., Eigler, A., Engelman, E., Geisler, B. & Trautman, M. (1994). Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection 22, 132-6.
61. Sanders, W. E. & Sanders, C. C. (1982). Do in vitro antimicrobial susceptibility tests accurately predict therapeutic responsiveness in infected patients? In Significance of Medical Microbiology in the Care of Patients, 2nd edn (Lorian, V., Ed.). Williams and Wilkins, Baltimore, MD.
62. Sandven, P., Bjorneklett, A., Maeland, A. and the Norwegian Yeast Study Group. (1993). Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrobial Agents and Chemotherapy 37, 2443-8.
63. Schaberg, D. R., Culver, D. H. & Gaynes, R. P. (1991). Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 91, Suppl. 3B, 72S-5.
64. Sewell, D. L., Pfaller, M. A. & Barry, A. L. (1994). Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. Journal of Clinical Microbiology 32, 2099-102.
65. St-Germain, G., Dion, C., Espinel-Ingroff, A., Ratelle, J. & de Reprentigny, L. (1995). Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV. Journal of Antimicrobial Chemotherapy 36, 109-18.
66. Stratton, C. W. (1991). In vitro testing: correlations between bacterial susceptibility, body fluid levels, and effectiveness of antibacterial therapy. In Antibiotics in Laboratory Medicine, 3rd edn. (Lorian, V., Ed.). pp. 847-79. Williams and Wilkins, Baltimore, MD.
67. Sugar, A. M. & Liu, X. (1995). Comparison of three methods of antifungal susceptibility testing with the proposed NCCLS standard broth macrodilution assay: lack of effect of phenol red. Diagnostic Microbiology and Infectious Disease 21, 129-33.
68. Tiballi, R. N., He, X., Zarins, L. f., Revankar, S. G. & Kauffmann, C. A. (1995). Use of a colorimetric system for yeast susceptibility testing. Journal of Clinical Microbiology 33, 915-7.
69. To, W. K., Fothergill, A. W. & Rinaldi, M. G. (1995). Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology 33, 2660-4.
70. Troillet, N., Durussel, C., Bille, J., Glauser, M. P. & Chave, J. P. (1993). Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV infected patients. European Journal of Clinical Microbiology and Infectious Disease 12, 911-5.
71. Wanger, A., Mills, K., Nelson, P. W. & Rex, J. H. (1995). Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrobial Agents and Chemotherapy 39, 2520-2.
72. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.
73. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E. & Saral, R. (1993). Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrobial Agents and Chemotherapy 37, 1847-9.
74. Wardle, H. M., Law, D., Moore, C. B., Mason, C. & Denning, D. W. (1995). In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrobial Agents and Chemotherapy 39, 868-71.